Department of Pathology, Microbiology, & Immunology, Vanderbilt University Medical Center & School of Medicine, Nashville, TN 37232, USA.
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA.
Future Microbiol. 2018 Dec;13(16):1697-1708. doi: 10.2217/fmb-2018-0258. Epub 2018 Dec 14.
As one of the most recent additions to the syndromic testing landscape, the ePlex platform by GenMark Diagnostics is a system that combines the manufacturer's signature electrochemical detection technology with updated microfluidics, providing a new option for multiplex testing that is both rapid and requires minimal hands-on steps. In this review, we detail the ePlex platform and its current/future syndromic panels, with a particular focus on the respiratory pathogen panel - the platform's first assay to undergo clinical trials and receive regulatory approval in the USA. By keeping informed of these ever-expanding laboratory options, clinicians and microbiologists can stay positioned at the forefront of infectious disease diagnosis.
作为最新加入综合征检测领域的产品之一,GenMark Diagnostics 的 ePlex 平台是一种将制造商的标志性电化学检测技术与更新的微流控技术相结合的系统,为快速且需要最少手动步骤的多重检测提供了新的选择。在这篇综述中,我们详细介绍了 ePlex 平台及其当前/未来的综合征检测试剂盒,特别关注呼吸道病原体检测试剂盒——这是该平台的首个进行临床试验并获得美国监管机构批准的检测试剂盒。通过了解这些不断扩展的实验室检测选项,临床医生和微生物学家可以站在传染病诊断的最前沿。